Literature DB >> 22660924

Approach to cardiovascular disease prevention in patients with chronic kidney disease.

Cristina Karohl1, Paolo Raggi.   

Abstract

OPINION STATEMENT: Chronic kidney disease (CKD) is associated with a large burden of cardiovascular risk factors ultimately leading to increased cardiovascular events and mortality. Prevention of cardiovascular disease (CVD) in CKD involves early identification of individuals at high-risk of renal disease. In fact, substantial evidence points to a complex bidirectional relationship between CKD and CVD. Therefore, most interventions directed at CKD prevention should include multiple risk factor interventions with the goal of preventing CVD events while slowing progression of CKD. Clearly, prevention of CVD in CKD is a complex task and requires a multidisciplinary team approach, with a well-defined program, rational targets for each risk factor, and implementation of the most effective intervention strategies. Although several interventions to prevent CVD have proven effective in the general population and in individuals at high risk for CVD, a true benefit in patients with CKD remains to be demonstrated for several of them. A few rational targets of intervention should be optimal blood pressure control, reduction of proteinuria, treatment of dyslipidemia, good control of diabetes, smoking cessation, dietary salt restriction, achievement of normal body mass index, partial correction of anemia, and management of mineral metabolism abnormalities. Lifestyle modification and pharmacological therapy with renin-angiotensin blockers, β-blockers, diuretics, statins, and aspirin should be encouraged in the early stages of CKD.

Entities:  

Year:  2012        PMID: 22660924     DOI: 10.1007/s11936-012-0189-2

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  106 in total

1.  Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity).

Authors:  Paul D Thompson; David Buchner; Ileana L Pina; Gary J Balady; Mark A Williams; Bess H Marcus; Kathy Berra; Steven N Blair; Fernando Costa; Barry Franklin; Gerald F Fletcher; Neil F Gordon; Russell R Pate; Beatriz L Rodriguez; Antronette K Yancey; Nanette K Wenger
Journal:  Circulation       Date:  2003-06-24       Impact factor: 29.690

2.  Renal Association Clinical Practice Guideline on cardiovascular disease in CKD.

Authors:  Stephen Holt; David Goldsmith
Journal:  Nephron Clin Pract       Date:  2011-05-06

Review 3.  The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Authors:  Daniel G Hackam; Nadia A Khan; Brenda R Hemmelgarn; Simon W Rabkin; Rhian M Touyz; Norman R C Campbell; Raj Padwal; Tavis S Campbell; M Patrice Lindsay; Michael D Hill; Robert R Quinn; Jeff L Mahon; Robert J Herman; Ernesto L Schiffrin; Marcel Ruzicka; Pierre Larochelle; Ross D Feldman; Marcel Lebel; Luc Poirier; J Malcolm O Arnold; Gordon W Moe; Jonathan G Howlett; Luc Trudeau; Simon L Bacon; Robert J Petrella; Alain Milot; James A Stone; Denis Drouin; Jean-Martin Boulanger; Mukul Sharma; Pavel Hamet; George Fodor; George K Dresser; S George Carruthers; George Pylypchuk; Ellen D Burgess; Kevin D Burns; Michel Vallée; G V Ramesh Prasad; Richard E Gilbert; Lawrence A Leiter; Charlotte Jones; Richard I Ogilvie; Vincent Woo; Philip A McFarlane; Robert A Hegele; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2010-05       Impact factor: 5.223

4.  Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.

Authors:  Jane L Finch; Masanori Tokumoto; Hironori Nakamura; Wei Yao; Mohammad Shahnazari; Nancy Lane; Eduardo Slatopolsky
Journal:  Am J Physiol Renal Physiol       Date:  2010-03-03

5.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

6.  Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl.

Authors:  Sharon M Moe; Glenn M Chertow; Jack W Coburn; L Darryl Quarles; William G Goodman; Geoffrey A Block; Tilman B Drüeke; John Cunningham; Donald J Sherrard; Laura C McCary; Kurt A Olson; Stewart A Turner; Kevin J Martin
Journal:  Kidney Int       Date:  2005-02       Impact factor: 10.612

7.  Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.

Authors:  Folkert W Asselbergs; Gilles F H Diercks; Hans L Hillege; Ad J van Boven; Wilbert M T Janssen; Adriaan A Voors; Dick de Zeeuw; Paul E de Jong; Dirk J van Veldhuisen; Wiek H van Gilst
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

Review 8.  Vitamin D deficiency and risk for cardiovascular disease.

Authors:  Suzanne E Judd; Vin Tangpricha
Journal:  Am J Med Sci       Date:  2009-07       Impact factor: 2.378

9.  Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial.

Authors:  Stuart M Sprague; Hanna Abboud; Ping Qiu; Matthew Dauphin; Pinggao Zhang; William Finn
Journal:  Clin J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 8.237

10.  Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.

Authors:  Uzma F Mehdi; Beverley Adams-Huet; Philip Raskin; Gloria L Vega; Robert D Toto
Journal:  J Am Soc Nephrol       Date:  2009-11-19       Impact factor: 10.121

View more
  1 in total

1.  Soluble Tumor Necrosis Factor Like Weak Inducer of Apoptosis and Vitamin D in Hemodialysis Patients: Relation to Carotid Intima-Media Thickness.

Authors:  Farahnaz Askarian; Amir Ghorbanihaghjo; Hassan Argani; Davoud Sanajou; Nima Nasehi; Roya Askarian; Ravan Ahmadi; Nadereh Rahtchizadeh
Journal:  Indian J Clin Biochem       Date:  2017-07-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.